The retinoid signalling molecule, TRIM16, is repressed during squamous cell carcinoma skin carcinogenesis in vivo and reduces skin cancer cell migration in vitro

Retinoid therapy is used for chemo-prevention in immuno-suppressed patients at high risk of developing skin cancer. The retinoid signalling molecule, tripartite motif protein 16 (TRIM16), is a regulator of keratinocyte differentiation and a tumour suppressor in retinoid-sensitive neuroblastoma. We s...

Cijeli opis

Spremljeno u:
Bibliografski detalji
Glavni autori: Cheung, Belamy B, Koach, Jessica, Tan, Owen, Kim, Patrick, Bell, Jessica L, D'andreti, Carla, Sutton, Selina, Malyukova, Alena, Sekyere, Eric, Norris, Murray, Haber, Michelle, Kavallaris, Maria, Cunningham, Anne M, Proby, Charlotte, Leigh, Irene, Wilmott, James S, Cooper, Caroline L, Halliday, Gary M, Scolyer, Richard A, Marshall, Glenn M
Format: Artigo
Jezik:Inglês
Izdano: John Wiley & Sons, Ltd. 2012
Teme:
Original Papers
Online pristup:https://ncbi.nlm.nih.gov/pmc/articles/PMC3504077/
https://ncbi.nlm.nih.gov/pubmed/22009481
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/path.2986
Oznake: Dodaj oznaku
Bez oznaka, Budi prvi tko označuje ovaj zapis!

Similar Items